Literature DB >> 12368122

The use of pressure immobilization bandages in the first aid management of cubozoan envenomings.

Jamie Seymour1, Teresa Carrette, Paul Cullen, Mark Little, Richard F Mulcahy, Peter L Pereira.   

Abstract

This study is aimed to evaluate whether the application of pressure results in additional release of venom from naturally discharged, vinegar soaked nematocysts of the box jellyfish Chironex fleckeri. The results show that large quantities of venom are expressed with the application of pressures similar to that applied by compression immobilization bandages. The volume of venom expressed by this pressure was similar to the quantity expressed upon initial natural discharge of the nematocysts. The current recommended practice of applying PIB to cubozoan stings might worsen the envenomation. As the existing data now show that PIB may be detrimental to victims envenomed by cubozoans, we suggest that the current practice of the use of PIB in cubozoan envenomings be discarded until there is direct experimental evidence to support its use. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12368122     DOI: 10.1016/s0041-0101(02)00152-6

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  4 in total

Review 1.  [Jellyfish sting injuries].

Authors:  D Mebs
Journal:  Hautarzt       Date:  2014-10       Impact factor: 0.751

Review 2.  Interventions for the symptoms and signs resulting from jellyfish stings.

Authors:  Li Li; Richard G McGee; Geoff Isbister; Angela C Webster
Journal:  Cochrane Database Syst Rev       Date:  2013-12-09

Review 3.  Jellyfish stings and their management: a review.

Authors:  Luca Cegolon; William C Heymann; John H Lange; Giuseppe Mastrangelo
Journal:  Mar Drugs       Date:  2013-02-22       Impact factor: 5.118

4.  Anticancer Effect of Nemopilema nomurai Jellyfish Venom on HepG2 Cells and a Tumor Xenograft Animal Model.

Authors:  Hyunkyoung Lee; Seong Kyeong Bae; Munki Kim; Min Jung Pyo; Minkyung Kim; Sujeoung Yang; Chung-Kil Won; Won Duk Yoon; Chang Hoon Han; Changkeun Kang; Euikyung Kim
Journal:  Evid Based Complement Alternat Med       Date:  2017-07-13       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.